Literature DB >> 18493720

Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).

Daizo Yoshida1, Ryutaro Nomura, Akira Teramoto.   

Abstract

Degradation and remodelling of the extracellular matrix has been investigated, with the main focus on the balance between matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases (TIMP). Recent reports disclose the presence of a novel MMP-inhibiting cell membrane-anchored glycoprotein designated 'reversion-inducing cysteine-rich protein with Kazal motifs' (RECK). Our main aim in this study was to elucidate the role of RECK in cell invasion of pituitary adenomas and its contribution to signal transduction. The function of RECK in cell invasion was investigated by comparing data obtained from full-length RECK clone transfection and gene silencing with RECK mRNA-targeting siRNA. RECK expression was confirmed using real-time RT-PCR and Western blotting. Levels of matrix metalloproteinases (MMP-2 and -9) and TIMP-1 were measured by zymography and reverse zymography, respectively. Cell invasion was examined with a 3-D invasion assay. The signal cascade was investigated by cDNA microarray analysis. As expected, expression of RECK was elevated upon cDNA transfection, and diminished using siRNA. We observed elevation of MMP-2 and -9 expression and consequent 3-D cell invasion in cells under-expressing RECK. However, TIMP expression was not affected by RECK. Analysis with cDNA microarray revealed that RECK additionally upregulates growth hormone-releasing hormone receptor (GHRHR) and latrophilin 2 at the transcriptional level. Our findings collectively suggest that RECK regulates the cell signalling pathway, playing a critical neuroendocrinological role in the pituitary adenoma cell line.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493720     DOI: 10.1007/s11060-008-9606-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.

Authors:  Weiping Liu; Katsuzo Kunishio; Yoshihito Matsumoto; Masaki Okada; Seigo Nagao
Journal:  J Clin Neurosci       Date:  2005-09       Impact factor: 1.961

2.  Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.

Authors:  S Takagi; Y Hoshino; T Osaki; M Okumura; T Fuginaga
Journal:  Exp Oncol       Date:  2007-03

3.  Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1.

Authors:  Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-09-26       Impact factor: 4.130

4.  Role of matrix metalloproteinase 9 in pituitary tumor behavior.

Authors:  H E Turner; Z Nagy; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK.

Authors:  Satoshi Takagi; Takanori Kitamura; Yoshinao Hosaka; Tomohiro Ohsaki; Darko Bosnakovski; Tsuyoshi Kadosawa; Masahiro Okumura; Toru Fujinaga
Journal:  J Vet Med Sci       Date:  2005-04       Impact factor: 1.267

6.  Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.

Authors:  Huang-Chou Chang; Chun-Yu Cho; Wen-Chun Hung
Journal:  Cancer Sci       Date:  2007-02       Impact factor: 6.716

7.  Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat.

Authors:  Thais Accorsi-Mendonça; Katiúcia Batista da Silva Paiva; Willian Fernando Zambuzzi; Tânia Mary Cestari; Vanessa Soares Lara; Mari Cleide Sogayar; Rumio Taga; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2007-11-07       Impact factor: 2.611

Review 8.  RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Authors:  Jonathan C M Clark; David M Thomas; Peter F M Choong; Crispin R Dass
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

9.  MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.

Authors:  Riyad Bendardaf; Abdelbaset Buhmeida; Raija Ristamäki; Kari Syrjänen; Seppo Pyrhönen
Journal:  Scand J Gastroenterol       Date:  2007-12       Impact factor: 2.423

10.  Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.

Authors:  Ulrich J Knappe; Christian Hagel; Björn W Lisboa; Waldemar Wilczak; Dieter K Lüdecke; Wolfgang Saeger
Journal:  Acta Neuropathol       Date:  2003-08-02       Impact factor: 17.088

View more
  6 in total

1.  The metalloproteinase inhibitor Reck is essential for zebrafish DRG development.

Authors:  Andrew Prendergast; Tor H Linbo; Tanya Swarts; Josette M Ungos; Hillary F McGraw; Shlomo Krispin; Brant M Weinstein; David W Raible
Journal:  Development       Date:  2012-02-01       Impact factor: 6.868

2.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.

Authors:  Tony Gutschner; Monika Hämmerle; Moritz Eissmann; Jeff Hsu; Youngsoo Kim; Gene Hung; Alexey Revenko; Gayatri Arun; Marion Stentrup; Matthias Gross; Martin Zörnig; A Robert MacLeod; David L Spector; Sven Diederichs
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

3.  Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.

Authors:  Bin Zhang; Jin Zhang; Zhi-Ying Xu; Hong-Liang Xie
Journal:  BMC Cancer       Date:  2009-12-08       Impact factor: 4.430

4.  RECK (reversion-inducing cysteine-rich protein with Kazal motifs) regulates migration, differentiation and Wnt/β-catenin signaling in human mesenchymal stem cells.

Authors:  Christian Mahl; Virginia Egea; Remco T A Megens; Thomas Pitsch; Donato Santovito; Christian Weber; Christian Ries
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

Review 5.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

Review 6.  Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.

Authors:  Hong-Yan Liu; Wei-Jun Gu; Cheng-Zhi Wang; Xiao-Jian Ji; Yi-Ming Mu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.